Netrin-3 attenuates metabolic dysfunction-associated fatty liver disease by activating the AMPK-PPARα axis

BACKGROUND: Metabolic dysfunction-associated fatty liver disease (MAFLD) is characterized by hepatic steatosis and can progress to steatohepatitis. Netrin-3, an axon guidance protein linked to metabolic homeostasis, has not been characterized in MAFLD. METHODS: MAFLD was induced in mice by high-fat diet. Netrin-3 and UNC5A expression was measured in serum and liver. Recombinant Netrin-3 was administered with or without Compound C. Hepatic AMPK/ACC phosphorylation, PPARα and target genes, lipid and glucose profiles, insulin, and liver injury were assessed. AML12 hepatocytes with fatty acid overload were treated with Netrin-3, Compound C, or AMPKα siRNA. RESULTS: Netrin-3 and UNC5A were downregulated in MAFLD mice. Netrin-3 treatment reduced body weight, adiposity, dyslipidemia, hyperglycemia, hyperinsulinemia, ALT/AST levels, and hepatic steatosis. It increased AMPK and ACC phosphorylation and restored PPARα, Fabp1, and CPT1α expression. Compound C reversed these protective effects in vivo. In AML12 cells, Netrin-3 activated AMPK/ACC signaling, and this effect was abolished by Compound C and AMPKα siRNA. CONCLUSIONS: Netrin-3 attenuates MAFLD progression by activating the hepatic AMPK-PPARα axis and promoting fatty acid oxidation, identifying Netrin-3 as a candidate therapeutic molecule for fatty liver disease.

Authors

Institutions

Publication Details

Journal
Archives of Physiology and Biochemistry
Published
2026-11-17
DOI
https://doi.org/10.1080/13813455.2026.2752268
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Netrin-3 attenuates metabolic dysfunction-associated fatty liver disease by activating the AMPK-PPARα axis

Feng Dong, Zhenfei Hong
5 links
Archives of Physiology and Biochemistry
Liver Disease Diagnosis and Treatment
article

Netrin-3 attenuates metabolic dysfunction-associated fatty liver disease by activating the AMPK-PPARα axis

Feng Dong, Zhenfei Hong
article en

Abstract

BACKGROUND: Metabolic dysfunction-associated fatty liver disease (MAFLD) is characterized by hepatic steatosis and can progress to steatohepatitis. Netrin-3, an axon guidance protein linked to metabolic homeostasis, has not been characterized in MAFLD. METHODS: MAFLD was induced in mice by high-fat diet. Netrin-3 and UNC5A expression was measured in serum and liver. Recombinant Netrin-3 was administered with or without Compound C. Hepatic AMPK/ACC phosphorylation, PPARα and target genes, lipid and glucose profiles, insulin, and liver injury were assessed. AML12 hepatocytes with fatty acid overload were treated with Netrin-3, Compound C, or AMPKα siRNA. RESULTS: Netrin-3 and UNC5A were downregulated in MAFLD mice. Netrin-3 treatment reduced body weight, adiposity, dyslipidemia, hyperglycemia, hyperinsulinemia, ALT/AST levels, and hepatic steatosis. It increased AMPK and ACC phosphorylation and restored PPARα, Fabp1, and CPT1α expression. Compound C reversed these protective effects in vivo. In AML12 cells, Netrin-3 activated AMPK/ACC signaling, and this effect was abolished by Compound C and AMPKα siRNA. CONCLUSIONS: Netrin-3 attenuates MAFLD progression by activating the hepatic AMPK-PPARα axis and promoting fatty acid oxidation, identifying Netrin-3 as a candidate therapeutic molecule for fatty liver disease.

Archives of Physiology and Biochemistry
Shanghai Ship and Shipping Research Institute (CN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon